Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase
04:15pm, Wednesday, 25'th Feb 2026
FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the considerat
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
08:00am, Wednesday, 25'th Feb 2026
FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the early tend
BD Launches Urine Complete Cup Kit for Smarter Testing & Accuracy
01:41pm, Tuesday, 24'th Feb 2026
BDX launches a three-tube urine collection kit to expand testing from one sample, aiming to boost lab efficiency and reduce contamination risks.
BD to Present at Barclays 28th Annual Global Healthcare Conference
04:15pm, Monday, 23'rd Feb 2026
FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 2
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency
06:50am, Monday, 23'rd Feb 2026
The BD Vacutainer® Urine Complete Cup Kit preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient care FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNe
Lanesha Minnix Named General Counsel for BD
04:15pm, Thursday, 19'th Feb 2026
FRANKLIN LAKES, N.J., Feb. 19, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Lanesha Minnix has been named exec
BD Merges Biosciences & Diagnostics Business With Waters
02:35pm, Wednesday, 11'th Feb 2026
BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.
What's Going On With Becton Dickinson Stock Tuesday?
02:17pm, Tuesday, 10'th Feb 2026
The company reported sales of $5.25 billion, slightly above the consensus of $5.15 billion.
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
01:00pm, Tuesday, 10'th Feb 2026
FRANKLIN LAKES, N.J., Feb. 10, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced that it has com
Becton, Dickinson and Company (BDX) Q1 2026 Earnings Call Transcript
12:04pm, Monday, 09'th Feb 2026
Becton, Dickinson and Company (BDX) Q1 2026 Earnings Call Transcript
BD Stock Dips in Pre-Market Despite Q1 Earnings Beat, Margins Up
11:41am, Monday, 09'th Feb 2026
BDX posts an earnings beat with revenue growth and expanding margins in first-quarter fiscal 2026 quarter, though adjusted profit declined year over year.
Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings
10:01am, Monday, 09'th Feb 2026
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 250 points on Monday.
Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit
08:43am, Monday, 09'th Feb 2026
Medical device maker Becton Dickinson cut its profit forecast for fiscal year 2026 on Monday, adjusting its outlook to account for the separation and sale of its biosciences and diagnostics unit to la
Becton Dickinson (BDX) Beats Q1 Earnings and Revenue Estimates
08:40am, Monday, 09'th Feb 2026
Becton Dickinson (BDX) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.82 per share. This compares to earnings of $3.43 per share a year ago.
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
08:40am, Monday, 09'th Feb 2026
Announces appointment of Claire M. Fraser, Ph.D.
